Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual revenue forecast on Tuesday, citing lower-than-expected ...

Southwest District Health ended its COVID-19 vaccination program. Others in Texas, Florida and Michigan also pushed back ...

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to ...

A disturbance swirling in the Caribbean Sea developed into Tropical Depression Nineteen early Thursday morning. Forecasters ...

The data from the CDC's National Immunization Survey estimates that 37.6% of Americans ages 65 and older had gotten a shot of ...

In her religious excemption request, Lisa Domski wrote that taking the vaccine “would be a terrible sin and distance my ...

Nov. 4 (UPI) --A new study indicates what researchers describe as an ongoing "stubborn mistrust" in science among the ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.

The study was based on outcomes seen among essential workers with COVID-19 infection from June 2021 to September 2022.

More than a third of Americans continue to express mistrust in the science behind COVID vaccines, a new study finds.

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...